diclofenac has been researched along with Cholangitis, Sclerosing in 1 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
Cholangitis, Sclerosing: Chronic inflammatory disease of the BILIARY TRACT. It is characterized by fibrosis and hardening of the intrahepatic and extrahepatic biliary ductal systems leading to bile duct strictures, CHOLESTASIS, and eventual BILIARY CIRRHOSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The European Society of Gastrointestinal Endoscopy recommends rectal indomethacin or diclofenac before endoscopic retrograde cholangiopancreatography (ERCP) to prevent post-ERCP pancreatitis." | 7.96 | Diclofenac does not reduce the risk of acute pancreatitis in patients with primary sclerosing cholangitis after endoscopic retrograde cholangiography. ( Färkkilä, M; Jokelainen, K; Koskensalo, V; Kylänpää, L; Lindström, O; Rainio, M; Tenca, A; Udd, M, 2020) |
| "The European Society of Gastrointestinal Endoscopy recommends rectal indomethacin or diclofenac before endoscopic retrograde cholangiopancreatography (ERCP) to prevent post-ERCP pancreatitis." | 3.96 | Diclofenac does not reduce the risk of acute pancreatitis in patients with primary sclerosing cholangitis after endoscopic retrograde cholangiography. ( Färkkilä, M; Jokelainen, K; Koskensalo, V; Kylänpää, L; Lindström, O; Rainio, M; Tenca, A; Udd, M, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koskensalo, V | 1 |
| Tenca, A | 1 |
| Udd, M | 1 |
| Lindström, O | 1 |
| Rainio, M | 1 |
| Jokelainen, K | 1 |
| Kylänpää, L | 1 |
| Färkkilä, M | 1 |
1 other study available for diclofenac and Cholangitis, Sclerosing
| Article | Year |
|---|---|
Diclofenac does not reduce the risk of acute pancreatitis in patients with primary sclerosing cholangitis after endoscopic retrograde cholangiography.
Topics: Administration, Rectal; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Case-Contr | 2020 |